IP Library Granted Patent US 10,451,608
Granted Patent B2
US 10,451,608 · App. 15/153,305 · Granted Oct 22, 2019

Cell line, system and method for optical-based screening of ion-channel modulators

Inventors: Karl Deisseroth (Stanford, CA); Feng Zhang (Cambridge, MA); Viviana Gradinaru (Menlo Park, CA); M. Bret Schneider (Portola Valley, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
G01N33/502A61N5/0622C40B60/12G01N33/5008G01N33/6872B01J2219/00315B01J2219/00495B01J2219/00702
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,451,608
App. No.
15/153,305
Granted
Oct 22, 2019
Kind
B2
Abstract

A variety of applications, systems, methods and constructs are implemented for use in connection with screening of ion-channel modulators. Consistent with one such system, drug candidates are screened to identify their effects on cell membrane ion channels and pumps. The system includes screening cells having light responsive membrane ion switches, voltage-gated ion switches and fluorescence producing voltage sensors. A chemical delivery device introduces the drug candidates to be screened. An optical delivery device activates the light responsive ion switches. An optical sensor monitors fluorescence produced by the voltage sensors. A processor processes data received from the optical sensor. A memory stores the data received from the optical sensor.

Claims (11)

1. A system for screening drug candidates to identify their effects on cell membrane ion channels and pumps, the system comprising:

a genetically modified mammalian cell, wherein the cell is genetically modified to express a heterologous, microbial light-responsive ChR2 ion channel and a heterologous, microbial light-responsive NpHR ion pump, wherein the cell comprises a voltage-gated ion channel and a fluorescence producing voltage sensor;

a chemical delivery device for introducing the drug candidates to be screened;

an optical delivery device to activate the light responsive ion switches; and

an optical sensor to monitor fluorescence produced by the voltage sensors.

2. The system of claim 1 , wherein the voltage-gated ion channel is a Ca2 + channel.

3. The system of claim 1 , wherein the cell further comprises an indicator.

4. The system of claim 1 , further comprising an array of wells each containing a portion of the screening cells and an array of optical sensors for detecting light from respective wells from the array of wells.

5. The system of claim 1 , further comprising a processor to process data received from the optical sensor.

6. The system of claim 1 , further comprising memory for storing the data received from the optical sensor.

7. The system of claim 3 , wherein the indicator is a calcium indicator.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 24, 2018
From: STANFORD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046007/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2016
From: DEISSEROTH, KARL; ZHANG, FENG; GRADINARU, VIVIANA; SCHNEIDER, M. BRET
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 038639/0456 →
Continuity (7)
Continuation 13850436 · Mar 26, 2013
Division 12187927 · Aug 7, 2008
Continuation In Part 11651422 · Jan 9, 2007
Continuation In Part 11459636 · Jul 24, 2006
Provisional Application 60955116 · Aug 10, 2007
Provisional Application 60701799 · Jul 22, 2005
Related Publication 20160258929A1 · Sep 8, 2016